The myo-1,2-Diaminocyclitol Scaffold Defines Potent Glucocerebrosidase Activators and Promising Pharmacological Chaperones for Gaucher Disease.
about
Glucocerebrosidase inhibitors for the treatment of Gaucher disease.Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases.Bicyclic derivatives of L-idonojirimycin as pharmacological chaperones for neuronopathic forms of Gaucher disease.Regioselective SN2 reactions for rapid syntheses of azido-inositols by one-pot sequence-specific nucleophilysis.Gluco-1 H-imidazole: A New Class of Azole-Type β-Glucosidase Inhibitor.
P2860
The myo-1,2-Diaminocyclitol Scaffold Defines Potent Glucocerebrosidase Activators and Promising Pharmacological Chaperones for Gaucher Disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The myo-1,2-Diaminocyclitol Sc ...... haperones for Gaucher Disease.
@en
The myo-1,2-Diaminocyclitol Sc ...... haperones for Gaucher Disease.
@nl
type
label
The myo-1,2-Diaminocyclitol Sc ...... haperones for Gaucher Disease.
@en
The myo-1,2-Diaminocyclitol Sc ...... haperones for Gaucher Disease.
@nl
prefLabel
The myo-1,2-Diaminocyclitol Sc ...... haperones for Gaucher Disease.
@en
The myo-1,2-Diaminocyclitol Sc ...... haperones for Gaucher Disease.
@nl
P2860
P356
P1476
The myo-1,2-Diaminocyclitol Sc ...... Chaperones for Gaucher Disease
@en
P2093
Amadeu Llebaria
Ana Trapero
P2860
P304
P356
10.1021/ML200098J
P577
2011-05-18T00:00:00Z